It's looking likely that the Pharmaceutical Research and Manufacturers of America wasted up to $100 million in advertising to promote a health-care-reform bill that will ultimately offer the industry no protection.
Pharma-White House deal imperiled despite $100M outlay
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.